Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Colorado, Denver

About this trial

The primary objectives of this study are to determine whether exercise training is an effective strategy for treatment of Long COVID and characterize the cardiorespiratory and autonomic physiology in these patients to precisely characterize mechanisms contributing to this syndrome.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults ≥18 years with documented history of COVID-19 infection and symptoms consistent with Long COVID lasting >12 weeks after diagnosis.

Disqualifiers

History of cardiovascular/pulmonary disease prior to infection

COVID-related myocardial injury such as evidence of myocarditis

Deep vein thrombosis/pulmonary embolism following COVID-19 infection

Exercise intolerance resulting from conditions that are not related to cardiorespiratory or autonomic factors (e.g. osteoarthritis or other musculoskeletal diseases);

Trial design

Design model

Single group

Treatments tested in this trial

  • Exercise

    Behavioral

    exercise protocol

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: ExerciseExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Characterizing the impact of exercise training (cardiac rehabilitation) on functional capacity among patients with Long COVID

functional capacity as determined by VO2max

Time frame
12 weeks
2

Characterizing the impact of exercise training (cardiac rehabilitation) on HRqOL among patients with Long COVID

Health-related quality of life (HRqOL) from SF-36 form; all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively.

Time frame
12 weeks

Secondary outcomes

1

orthostatic challenge

Heart rate during orthostatic challenge

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.